Latest GM & Biosafety Resources
25 February 2013
GM Industry Called to Account: ISAAA’s report mischievous and erroneous
The Africa Centre for Biosafety (ACB) has dismissed the findings of the biotechnology industry’s flagship annual report, published by the GM industry funded ‘NGO’, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), as mischievous and erroneous. According to the report, South Africa’s GM crop area increased by a record 26% or 600,000 hectares […]
READ24 March 2011
GM cotton in SA
The biotechnology industry has really tried to win small-scale farmers over to genetically modified (GM) cotton, especially in Africa and Asia. Getting cotton approved in a country is a good way for the industry to pave the way for the entry of GM food crops. It is estimated that farmers around the globe planted about […]
READ31 May 2010
ACB’s objection to Monsanto’s commodity clearance application for Smartstax
On 20 April, Business Day carried a public notice of Monsanto’s application to the South African GMO registrar for permission to import Smartstax maize, arguably the world’s most controversial and risky commercially grown GMO. While the majority of commercially grown genetically engineered crops contain at most 3 foreign genes, Smartstax contains eight, 6 of which […]
READ11 February 2007
Lesotho – GMO Legislation
Evidently influenced by the UNEP-GEF Biosafety Project, the Biosafety Bill has been drafted principally to implement the Biosafety Protocol verbatim, and in so doing, perpetuates some of the weaknesses and deficiencies of the Biosafety Protocol. For instance, the scope of the Biosafety Bill is predicated on the scope of the Biosafety Protocol where the risks […]
READ11 May 2006
Mozambique – GMO Legislation
The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]
READ